Tracking tenecteplase for stroke in real-world settings
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study is collecting information on stroke patients who received the clot-dissolving drug tenecteplase. It aims to see how well the drug works and how safe it is in everyday hospital care in China.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Had an ischemic stroke (blocked artery in the brain) confirmed by a CT or MRI scan
- Received the clot-busting drug tenecteplase through an IV at the participating hospital
- Can provide signed permission (from you or a family member) to take part in the study
- Able to attend follow-up appointments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the clot-busting drug tenecteplase can help people with a moderate to severe stroke when given 24 to 72 hours after symptoms began. It aims to see if this later treatment window can improve recovery and reduce disability.
This trial tests whether giving a clot-busting medication (tenecteplase) directly into the artery after an incomplete clot-removal procedure can improve blood flow and outcomes in people with large vessel strokes. It aims to help those who had partial reopening after mechanical thrombectomy.
This trial studies the use of a clot-busting medicine called tenecteplase given more than 4.5 hours after a stroke starts. It aims to see if this treatment can help people who wake up with stroke symptoms or whose stroke time is unknown.
This trial tests a clot-busting drug called tenecteplase given directly into the brain artery for people having a moderate stroke caused by a blockage in a medium-sized blood vessel. The goal is to see if it helps improve recovery when given within 24 hours of stroke symptoms starting.
This study collects information from people who have had an ischemic stroke (a stroke caused by a blocked blood vessel in the brain) and were treated with the clot-busting drug tenecteplase. The goal is to learn more about how well this treatment works in everyday practice and how safe it is, which can help improve stroke care for future patients.
This study tests a clot-dissolving drug called tenecteplase given directly into the artery after a mechanical thrombectomy (clot removal). The goal is to see if it helps improve blood flow to the small vessels in the brain after the main clot is removed.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.